Extension of clinical data structured into the ImmPort model and cross-study data exploration and visualization user interface
Extension of clinical data structured into the ImmPort model and cross-study data exploration and visualization user interface
批准号:
10116065
负责人:
Sandra Andorf
金额:
$19.88万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-01 至 2022-05-31
关键词:
AddressAgeAreaBiological AssayBiomedical ResearchCharacteristicsClinicalClinical DataClinical ResearchClinical TrialsCollaborationsCommon Data ElementDataData ElementData FilesDatabase and Analysis PortalDatabasesDevelopmentDiseaseDisease ProgressionDocumentationEnsureExerciseFemaleFlow CytometryFood HypersensitivityFutureGene ExpressionGoalsHemagglutinationHypersensitivityImmune ToleranceImmunologicsImmunologyIndividualInformaticsMeasuresMethodsMiningModelingOncologyOrgan TransplantationParticipantPatientsPharmaceutical PreparationsProcessProtocols documentationPublishingRecurrenceReportingReproducibilityResearchResearch PersonnelResource SharingResourcesST14 geneScienceSpecific qualifier valueStandard ModelStandardizationStructureTerminologyTestingTextValidationVisualizationVocabularyWorkbaseclinical developmentdata accessdata explorationdata formatdata miningdata reusedata sharingdata sharing networksdata standardsdata visualizationdatabase structuredesignexperiencehuman leukocyte antigen testinginterestmultimodalitynovelprototyperepositorysecondary analysisstructured datatoolunstructured datausabilityweb page
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Sharing of biomedical research data facilitates independent validation of findings, the design of future clinical
trials and the reuse of data to test new hypothesis. One platform to share data is the Immunology Database and
Analysis Portal (ImmPort), a public warehouse providing open access to clinical and mechanistic data from
currently 341 immunological and clinical studies. In addition to valuable high-throughput data elements, ImmPort
provides access to individual-level data from clinical studies. Many of these clinical studies in ImmPort have an
abundance of data associated with them that is not annotated and parsed into the structured ImmPort MySQL
database model but made available as separate files in various different formats. In this form the data are not
readily available for data mining or secondary analysis. We will prioritize the unstructured data from clinical
studies for integration into the structured MySQL ImmPort model to facilitate better access and reuse. We further
will harmonize the used vocabularies in the database for which a preferred terminology is not yet established but
which is of high interest for secondary analyses. Currently, the mining of available data across studies in ImmPort
is a challenge for users who have no experience in informatics and, therefore, rely on the keyword search on
ImmPort’s web page. To address this critical need, we will develop an interactive cross-study data exploration
and visualization user interface for data in the ImmPort model including the functionality to create cross-study
exports. The data newly structure into the ImmPort model as well as the user interface will be integrated into
ImmPort and its web page. The treatments of several diseases (e.g. allergies, organ transplantation) rely on the
induction of immune tolerance. In ImmPort serval studies focus on different diseases but with the underlying
topic of immune tolerance. We will perform a secondary analysis of the shared individual-level clinical and
mechanistic data of these studies towards the identification of potential universal drivers of developing clinical
immune tolerance. This analysis will be used to develop a step-by-step tutorial for the interactive user interface.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: